Nyxoah (NYXH) Return on Capital Employed (2022 - 2026)
Nyxoah's (NYXH) quarterly Return on Capital Employed came in at 34436.59% in Q1 2026, down 5052851.0% year-on-year from N/an in Q1 2025, and down 281.41% quarter-over-quarter from 18982.58% in Q2 2025.
Nyxoah (NYXH) Return on Capital Employed (2022 - 2026) Analysis & Trends
Nyxoah's Return on Capital Employed history runs 5 years deep, the most recent figure standing at 34436.59% for Q1 2026.
- On a quarterly basis, Return on Capital Employed fell 5052851.0% year-over-year to 34436.59% in Q1 2026; TTM through Mar 2026 was 34436.59%, a 5052851.0% decrease from a year earlier, with the FY2025 full-year figure at 100.6%, down 5167.0% from the prior year.
- Return on Capital Employed fell to 34436.59% in Q1 2026 per NYXH's latest filing, from 18982.58% in the prior quarter.
- Across five years, Return on Capital Employed topped out at 25624.52% in Q4 2024 and bottomed at 34436.59% in Q1 2026.
- The 5-year median for Return on Capital Employed is 16976.44% (2022), against an average of 13123.27%.
- Across the five-year window, Return on Capital Employed surged 1687353 bps in 2023 and sank 5052851 bps in 2026, its largest moves.
- Year by year, Return on Capital Employed stood at 17120.9% in 2022, then grew by 21 bps to 20669.09% in 2023, then climbed by 24 bps to 25624.52% in 2024, then declined by 26 bps to 18982.58% in 2025, then plunged by 281 bps to 34436.59% in 2026.
- Per Business Quant, the three latest NYXH Return on Capital Employed figures stand at 34436.59% (Q1 2026), 18982.58% (Q2 2025), and 16091.92% (Q1 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn | 28.56% |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn | 18.58% |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn | 5.02% |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn | - |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn | 25.95% |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn | 19.71% |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn | 4.68% |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn | 19.44% |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn | 12.74% |
| 10 | Nyxoah | 56.02 Mn | 103.00 Mn | 4.26 Mn | -34,436.59% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -34,436.59% |
| Jun 30, 2025 | 18,982.58% |
| Mar 31, 2025 | 16,091.92% |
| Dec 31, 2024 | 25,624.52% |
| Sep 30, 2024 | 19,383.24% |
| Jun 30, 2024 | 22,240.09% |
| Mar 31, 2024 | 24,317.80% |
| Dec 31, 2023 | 20,669.09% |
| Sep 30, 2023 | 16,831.98% |
| Jun 30, 2023 | 16,011.48% |
| Mar 31, 2023 | 16,215.40% |
| Dec 31, 2022 | 17,120.90% |
| Sep 30, 2022 | -41.56% |
| Mar 31, 2022 | 4,714.87% |